U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C43H67FN2O4S
Molecular Weight 727.066
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Fipravirimat

SMILES

[H][C@]12[C@@H](CC[C@@]1(CC[C@]3(C)[C@]2([H])CC[C@]4([H])[C@@]5(C)CC=C(C6=CC[C@](CF)(CC6)C(O)=O)C(C)(C)[C@]5([H])CC[C@@]34C)NCCN7CCS(=O)(=O)CC7)C(C)=C

InChI

InChIKey=YFSNREBZTKMFEB-DHGHKPCRSA-N
InChI=1S/C43H67FN2O4S/c1-29(2)31-12-19-43(45-22-23-46-24-26-51(49,50)27-25-46)21-20-40(6)33(36(31)43)8-9-35-39(5)15-13-32(38(3,4)34(39)14-16-41(35,40)7)30-10-17-42(28-44,18-11-30)37(47)48/h10,13,31,33-36,45H,1,8-9,11-12,14-28H2,2-7H3,(H,47,48)/t31-,33+,34-,35+,36+,39-,40+,41+,42+,43-/m0/s1

HIDE SMILES / InChI

Molecular Formula C43H67FN2O4S
Molecular Weight 727.066
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:16:25 UTC 2023
Edited
by admin
on Sat Dec 16 14:16:25 UTC 2023
Record UNII
M5FP5REG5Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Fipravirimat
USAN   INN  
Official Name English
fipravirimat [INN]
Common Name English
GSK3640254
Code English
FIPRAVIRIMAT [USAN]
Common Name English
(1R)-4-[17-{[2-(1,1-dioxo-1λ<sup>6</sup>--thiomorpholin-4-yl)ethyl]amino}-28-norlupa-2,20(29)-dien-3-yl]-1-(fluoromethyl)cyclohex-3-ene-1-carboxylic acid
Systematic Name English
GSK3640254A
Code English
GSK-3640254A
Code English
GSK-3640254
Code English
3-Cyclohexene-1-carboxylic acid, 4-[17-[[2-(1,1-dioxido-4-thiomorpholinyl)ethyl]amino]-28-norlupa-2,20(29)-dien-3-yl]-1-(fluoromethyl)-, (1R)-
Systematic Name English
Code System Code Type Description
PUBCHEM
118435805
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
CAS
1818867-24-1
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
USAN
LM-07
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
SMS_ID
300000026312
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
FDA UNII
M5FP5REG5Q
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
INN
12083
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
NCI_THESAURUS
C188596
Created by admin on Sat Dec 16 14:16:25 UTC 2023 , Edited by admin on Sat Dec 16 14:16:25 UTC 2023
PRIMARY
Related Record Type Details
TARGET ORGANISM->INHIBITOR
HIV maturation inhibitor: Exhibited robust antiviral activity against a panel of HIV-1 clinical isolates, with a mean EC50 of 9 nM
EC50
SALT/SOLVATE -> PARENT
EXCRETED UNCHANGED
Accounting for 44% of total radioactivity
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
INHIBITS THE CONVERSION OF P25 TO P24
CUMULATIVE EXCRETION
FECAL
Related Record Type Details
METABOLITE -> PARENT
Forms in bile in high amounts may be recirculated back into plasma.
METABOLITE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC